Literature DB >> 21868363

Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.

Maria Hatziapostolou1, Georgios Koukos, Christos Polytarchou, Filippos Kottakis, Oksana Serebrennikova, Athan Kuliopulos, Philip N Tsichlis.   

Abstract

The mitogen-activated protein kinase kinase kinase (MAPKKK or MAP3K) tumor progression locus 2 (Tpl2) is required for the transduction of signals initiated by the thrombin-activated G protein-coupled receptor (GPCR) protease-activated receptor-1 (PAR1), which promote reorganization of the actin cytoskeleton and cell migration. Here, we show that Tpl2 is activated through Gα(i2)-transduced GPCR signals. Activated Tpl2 promoted the phosphorylation and activation of phospholipase C-β3 (PLCβ(3)); consequently, Tpl2 was required for thrombin-dependent production of inositol 1,4,5-trisphosphate (IP(3)), IP(3)-mediated cytoplasmic calcium ion (Ca(2+)) signals, and the activation of classical and novel members of the protein kinase C (PKC) family. A PKC-mediated feedback loop facilitated extracellular signal-regulated kinase (ERK) activation in response to Tpl2 and contributed to the coordinate regulation of the ERK and Ca(2+) signaling pathways. Pharmacological and genetic studies revealed that stimulation of cell migration by Tpl2 depends on both of these pathways. Tpl2 also promoted Ca(2+) signals and cell migration from sphingosine 1-phosphate-responsive GPCRs, which also couple to Gα(i); from Wnt5a; and from the interleukin-1β (IL-1β) receptor, a member of the Toll-IL-1R (TIR) domain family. Our data provide new insights into the role of Tpl2 in GPCR-mediated Ca(2+) signaling and cell migration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868363      PMCID: PMC3340127          DOI: 10.1126/scisignal.2002006

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  55 in total

1.  Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.

Authors:  K M Erny; J Peli; J F Lambert; V Muller; H Diggelmann
Journal:  Oncogene       Date:  1996-11-07       Impact factor: 9.867

2.  KN-93 inhibition of G protein signaling is independent of the ability of Ca2+/calmodulin-dependent protein kinase II to phosphorylate phospholipase Cbeta3 on 537-Ser.

Authors:  C Yue; B M Sanborn
Journal:  Mol Cell Endocrinol       Date:  2001-04-25       Impact factor: 4.102

3.  Protein kinase C is regulated in vivo by three functionally distinct phosphorylations.

Authors:  L M Keranen; E M Dutil; A C Newton
Journal:  Curr Biol       Date:  1995-12-01       Impact factor: 10.834

4.  Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors.

Authors:  H Jiang; Y Kuang; Y Wu; A Smrcka; M I Simon; D Wu
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

Review 5.  Regulation of phosphoinositide-specific phospholipase C isozymes.

Authors:  S G Rhee; Y S Bae
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

6.  Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.

Authors:  D D Schlaepfer; K C Jones; T Hunter
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 7.  The extended protein kinase C superfamily.

Authors:  H Mellor; P J Parker
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

8.  Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src.

Authors:  D D Schlaepfer; T Hunter
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

9.  Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.

Authors:  J D Ceci; C P Patriotis; C Tsatsanis; A M Makris; R Kovatch; D A Swing; N A Jenkins; P N Tsichlis; N G Copeland
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

10.  Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase.

Authors:  C Patriotis; A Makris; J Chernoff; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more
  13 in total

1.  Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.

Authors:  Oksana B Serebrennikova; Christos Tsatsanis; Changchuin Mao; Elias Gounaris; Wenying Ren; Linda D Siracusa; Aristides G Eliopoulos; Khashayarsha Khazaie; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  The aquaporin 1 C-terminal tail is required for migration and growth of pulmonary arterial myocytes.

Authors:  Ning Lai; Julie Lade; Kyle Leggett; Xin Yun; Syeda Baksh; Eric Chau; Michael T Crow; Venkataramana Sidhaye; Jian Wang; Larissa A Shimoda
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

3.  Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.

Authors:  Irene Kyrmizi; Marianna Ioannou; Maria Hatziapostolou; Philip N Tsichlis; Dimitrios T Boumpas; Ioannis Tassiulas
Journal:  J Leukoc Biol       Date:  2013-07-29       Impact factor: 4.962

4.  Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.

Authors:  Karyn M Austin; Nga Nguyen; Golrokh Javid; Lidija Covic; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

5.  Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.

Authors:  Kathleen L Decicco-Skinner; Sarah A Jung; Tracy Tabib; J Curtis Gwilliam; Hepzibha Alexander; Sarah E Goodheart; Anand S Merchant; Mengge Shan; Caroline Garber; Jonathan S Wiest
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

6.  Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+ Influx through the Na+/Ca2+ Exchanger.

Authors:  Petros Andrikopoulos; Julius Kieswich; Steven M Harwood; Akemichi Baba; Toshio Matsuda; Olivier Barbeau; Keith Jones; Suzanne A Eccles; Muhammad M Yaqoob
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

7.  Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages.

Authors:  Marta López-Pelaéz; Stefano Fumagalli; Carlos Sanz; Clara Herrero; Susana Guerra; Margarita Fernandez; Susana Alemany
Journal:  Mol Biol Cell       Date:  2012-06-06       Impact factor: 4.138

8.  Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes.

Authors:  Hsi-Yi Yeh; Bing-Hsien Liu; Martin Sieber; Shan-Hui Hsu
Journal:  BMC Genomics       Date:  2014-01-05       Impact factor: 3.969

Review 9.  Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.

Authors:  Hye Won Lee; Han Yong Choi; Kyeung Min Joo; Do-Hyun Nam
Journal:  Int J Mol Sci       Date:  2015-02-25       Impact factor: 5.923

Review 10.  Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach.

Authors:  Lidija Covic; Athan Kuliopulos
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.